Cardiac Effect of FABP4 Inhibitor: A Novel Therapeutic Target for Diabetes Mellitus and Atherosclerosis

被引：0
|
作者：
Lamounier-Zepter, Valeria
Look, Christiane
Bornstein, Stefan R.
Morano, Ingo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A483 / A483
页数：1
相关论文
共 50 条
  • [1] FABP4 a novel therapeutic target in ischaemic stroke
    Bacigaluppi, Marco
    Martino, Gianvito
    EUROPEAN HEART JOURNAL, 2020, 41 (33) : 3181 - 3183
  • [2] Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus
    He, Yu-Long
    Chen, Meng-Ting
    Wang, Ting
    Zhang, Ming-Ming
    Li, Ying-Xia
    Wang, He-Yao
    Ding, Ning
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 224
  • [3] Identification of Andrographolide as a novel FABP4 inhibitor for osteoarthritis treatment
    Yang, Kuangyang
    Xie, Qian
    Liang, Jianhui
    Shen, Yanni
    Li, Ziqi
    Zhao, Na
    Wu, Yuanyan
    Liu, Lichu
    Zhang, Peng
    Hu, Chun
    Chen, Lei
    Wang, Yan
    PHYTOMEDICINE, 2023, 118
  • [4] Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer
    Sun, Naihui
    Zhao, Xing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus
    Furuhashi, Masato
    Hiramitsu, Shinya
    Mita, Tomohiro
    Fuseya, Takahiro
    Ishimura, Shutaro
    Omori, Akina
    Matsumoto, Megumi
    Watanabe, Yuki
    Hoshina, Kyoko
    Tanaka, Marenao
    Moniwa, Norihito
    Yoshida, Hideaki
    Ishii, Junnichi
    Miura, Tetsuji
    JOURNAL OF LIPID RESEARCH, 2015, 56 (12) : 2372 - 2380
  • [6] Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus
    Hui Ning
    Hong Tao
    Zhanping Weng
    Xingbo Zhao
    Acta Diabetologica, 2016, 53 : 891 - 898
  • [7] Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus
    Ning, Hui
    Tao, Hong
    Weng, Zhanping
    Zhao, Xingbo
    ACTA DIABETOLOGICA, 2016, 53 (06) : 891 - 898
  • [8] Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus
    Furuhashi, Masato
    Sakuma, Ichiro
    Morimoto, Takeshi
    Higashiura, Yukimura
    Sakai, Akiko
    Matsumoto, Megumi
    Sakuma, Mio
    Shimabukuro, Michio
    Nomiyama, Takashi
    Arasaki, Osamu
    Node, Koichi
    Ueda, Shinichiro
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [9] FABP4 as a therapeutic host target controlling SARS-CoV-2 infection
    Baazim, Hatoon
    Koyuncu, Emre
    Tuncman, Guerol
    Burak, M. Furkan
    Merkel, Lea
    Bahour, Nadine
    Karabulut, Ezgi Simay
    Lee, Grace Yankun
    Hanifehnezhad, Alireza
    Karagoz, Zehra Firat
    Foldes, Katalin
    Engin, Ilayda
    Erman, Ayse Gokce
    Oztop, Sidika
    Filazi, Nazlican
    Gul, Buket
    Ceylan, Ahmet
    Cinar, Ozge Ozgenc
    Can, Fusun
    Kim, Hahn
    Al-Hakeem, Ali
    Li, Hui
    Semerci, Fatih
    Lin, Xihong
    Yilmaz, Erkan
    Ergonul, Onder
    Ozkul, Aykut
    Hotamisligil, Gokhan S.
    EMBO MOLECULAR MEDICINE, 2025, 17 (03) : 414 - 440
  • [10] The significance of biomarkers such as FABP4 in gestational diabetes mellitus and the importance of rigorous peer review
    Jonatan Dereke
    Magnus Hillman
    Acta Diabetologica, 2017, 54 : 885 - 886
12345